⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SNY News
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
ドレン・バイオ、次世代B細胞枯渇療法の開発に向けてサノフィとの戦略的協業を拡大
businesswire.com
SNY
ADEL Signs $1.04 Billion Global License Agreement with Sanofi for ADEL-Y01, a Novel investigational Alzheimer's Disease Therapy
prnewswire.com
SNY
Vertigo Drugs Market Outlook Report 2026-2034 - Landscape Shift Towards Targeted Drug Regimens Over Blanket Suppression, Emphasizing Early Rehab and Non-Sedating Prophylactics - ResearchAndMarkets.com
businesswire.com
ABT
SNY
PFE
GSK
NVS
Scribe Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
businesswire.com
SNY
LLY
Dren Bio Expands Strategic Collaboration with Sanofi to Develop Next-Generation B-Cell Depletion Therapy
businesswire.com
SNY
Kyowa Kirin annonce la nomination proposée d'Abdul Mullick au poste de président et CEO, tandis que l'ancien CEO Masashi Miyamoto restera président du conseil
businesswire.com
SNY
NVS
Prolynx Secures $70 Million Series A to Advance Portfolio of Ultra-Long-Acting Obesity Candidates and Appoints Chris Boulton as Chief Executive Officer
globenewswire.com
AMGN
SNY
AZN
Press Release: Sanofi’s Qfitlia and Cablivi approved in China, expanding care for rare diseases
globenewswire.com
SNY
Azafaros Further Strengthens Its Board of Directors With Appointment of Biotech Entrepreneur Dr. Thierry Abribat
businesswire.com
AZN
SNY
Tristan Imbert co-opted as Independent Director
globenewswire.com
SNY
NVS